Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 37 clinical trials
featured
A single-arm, prospective, multicentre, open-label study to evaluate ofatumumab treatment effectiveness and patient-reported outcomes in patients with relapsing multiple sclerosis transitioning from dimethyl fumarate or fingolimod therapy

This study will look to see if ofatumumab works and is safe in adults with relapsing multiple sclerosis (MS) who are switching from their current oral medicines (dimethyl fumarate or fingolimod

fingolimod
disease or disorder
dimethyl fumarate
MRI
relapsing multiple sclerosis
  • 0 views
  • 17 May, 2021
  • 1 location
featured
Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis (OPTIMUM)

Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple

  • 284 views
  • 08 Nov, 2020
  • 1 location
featured
Exploring the safety and tolerability of conversion to dose-titrated Oral Siponimod in patients with advancing forms of relapsing multiple sclerosis: A 6-month open label, multi-center Phase IIIb study (EXCHANGE) Protocol Number: CBAF312AUS02

The purpose of the study is to see how safe it is and how well you tolerate changing the MS medicine you are taking currently for your MS to siponimod (an investigational drug for MS). The results of this study will help doctors decide if and when to switch patients …

teriflunomide
disease or disorder
fingolimod
dimethyl fumarate
glatiramer acetate
  • 61 views
  • 24 Nov, 2020
  • 1 location
featured
Evolution RMS1/RMS2 Studies

Join a clinical study researching an investigational medication for people with relapsing multiple sclerosis (RMS) The Evolution RMS1/RMS2 Studies are looking at an investigational medication for

relapsing multiple sclerosis
  • 82 views
  • 23 Nov, 2020
  • 1 location
featured
Clinical trial studying the effects of RPC1063 in RMS

Clinical trial studying the effects of RPC1063 in RMS

  • 190 views
  • 23 Nov, 2020
  • 1 location
featured
Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

  • 358 views
  • 08 Nov, 2020
  • 1 location
Long-term Safety Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).

ofatumumab
tetanus
pneumococcal conjugate vaccine
  • 234 views
  • 16 May, 2021
  • 261 locations
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab

The open label study to evaluate effectiveness of treatment with ofatumumab in patients transitioning from commonly used oral MS therapies - fingolimod or dimethyl fumarate, due to breakthrough disease.

fingolimod
dimethyl fumarate
ofatumumab
  • 0 views
  • 22 Jul, 2021
  • 117 locations
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)

Multiple Sclerosis (RMS).

teriflunomide
aubagio
evobrutinib
  • 0 views
  • 25 Jul, 2021
  • 259 locations